Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial

NCT ID: NCT06286865

Last Updated: 2024-02-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-20

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this randomised trial is to learn about the role of AI in clinical coding practice. The main question it aims to answer is:

Can the AI-based CAC system reduce the burden of clinical coding and also improve the quality of such coding? Participants will be asked to code clinical texts both while they use our CAC system and while they do not.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Once participants are recruited, they are randomly allocated to 2 groups without allocation concealment. Allocation concealment will not be relevant for clinical coders since it is known whether a participant is assisted or not, and we will not develop a placebo coding assistant. We will, however, conceal the allocation of subjects for the analyses.

In total, participants will code 20 clinical notes, where each note belongs to a single patient. The participants are asked to complete the experiment in 1 sitting without interruptions, and they cannot revisit or go back to previous notes. In the event that participants are interrupted, they are asked to exit the experiment, and any incomplete records are discarded as invalid.

The user study process can be summarized in the following steps:

1. Study participants are randomly allocated to group 1 and group 2.
2. To prepare participants for the experiment, a short video tutorial is played after the consent form is signed and right before the clinical coding task commences.
3. In period 1 with 10 clinical notes, group 1 uses the control interface, while group 2 uses the intervention interface.
4. Data are logged in the background using button presses (eg. time, assigned codes, and comments).
5. Then, there is an immediate crossover to period 2 for the last 10 clinical notes.
6. Data continue to be logged in the background using button presses.
7. At the end, participants in both groups will complete the system usability scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Easy-ICD interface

This arm uses our AI-based computer-assisted clinical coding (CAC) system, Easy-ICD

Group Type ACTIVE_COMPARATOR

Easy-ICD

Intervention Type OTHER

Easy-ICD is an AI-based computer-assisted clinical coding (CAC) system that helps clinical coder assign ICD-10 codes to clinical notes such as discharge summaries.

Control interface

This control arm uses an interface similar to Easy-ICD, but without the AI functionality

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Easy-ICD

Easy-ICD is an AI-based computer-assisted clinical coding (CAC) system that helps clinical coder assign ICD-10 codes to clinical notes such as discharge summaries.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* participant has coded clinical texts before, preferably ICD-10 coding
* is a healthcare professional, eg. clinician, nurse, professional coders
* can understand Swedish

Exclusion Criteria

* participants outside Norway and Sweden
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Research Council of Norway

OTHER

Sponsor Role collaborator

University Hospital of North Norway

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Taridzo Chomutare

Senior Researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hercules Dalianis, PhD

Role: PRINCIPAL_INVESTIGATOR

Norwegian Centre for E-health Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Norwegian Centre for E-health Research

Tromsø, Troms, Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Taridzo F Chomutare, PhD

Role: CONTACT

Phone: +4747680032

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Taridzo F Chomutare, PhD

Role: primary

Hercules Dalianis, PhD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Chomutare T, Lamproudis A, Budrionis A, Svenning TO, Hind LI, Ngo PD, Mikalsen KO, Dalianis H. Improving Quality of ICD-10 (International Statistical Classification of Diseases, Tenth Revision) Coding Using AI: Protocol for a Crossover Randomized Controlled Trial. JMIR Res Protoc. 2024 Mar 12;13:e54593. doi: 10.2196/54593.

Reference Type DERIVED
PMID: 38470476 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

260972(REK)

Identifier Type: -

Identifier Source: org_study_id